Global Equine Pharmaceuticals and Supplements Market Research Report 2025(Status and Outlook)

March 2025 | 236 pages | ID: GEB7A70D5B9EEN
Bosson Research

Abstracts

Report Overview

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

This report provides a deep insight into the global Equine Pharmaceuticals and Supplements market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Equine Pharmaceuticals and Supplements Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Equine Pharmaceuticals and Supplements market in any manner.

Global Equine Pharmaceuticals and Supplements Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Boehringer Ingelheim

Merck Animal Health

Zoetis

Bayer Animal Health

Elanco Animal Health

Dechra Veterinary Products

CEVA

Virbac

Norbrook Equine

Kyoritsu Seiyaku

Vetoquinol

Protexin Healthcare

Audevard

Ouro Fino Saude

Market Segmentation (by Type)

Pharmaceuticals

Supplements

Market Segmentation (by Application)

Thoroughbred Horse

Other Types of Horses

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Equine Pharmaceuticals and Supplements Market
• Overview of the regional outlook of the Equine Pharmaceuticals and Supplements Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Equine Pharmaceuticals and Supplements Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Equine Pharmaceuticals and Supplements
1.2 Key Market Segments
1.2.1 Equine Pharmaceuticals and Supplements Segment by Type
1.2.2 Equine Pharmaceuticals and Supplements Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Equine Pharmaceuticals and Supplements Market Overview
2.1 Global Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Equine Pharmaceuticals and Supplements Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Equine Pharmaceuticals and Supplements Product Life Cycle
3.3 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (2020-2025)
3.4 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2020-2025)
3.5 Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Equine Pharmaceuticals and Supplements Manufacturing Sites, Area Served, Product Type
3.8 Equine Pharmaceuticals and Supplements Market Competitive Situation and Trends
3.8.1 Equine Pharmaceuticals and Supplements Market Concentration Rate
3.8.2 Global 5 and 10 Largest Equine Pharmaceuticals and Supplements Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Equine Pharmaceuticals and Supplements Industry Chain Analysis
4.1 Equine Pharmaceuticals and Supplements Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Equine Pharmaceuticals and Supplements Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Equine Pharmaceuticals and Supplements Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Equine Pharmaceuticals and Supplements Market
5.7 ESG Ratings of Leading Companies
6 Global Equine Pharmaceuticals and Supplements Market by Region
6.1 Global Equine Pharmaceuticals and Supplements Market Size by Region
6.1.1 Global Equine Pharmaceuticals and Supplements Market Size by Region
6.1.2 Global Equine Pharmaceuticals and Supplements Market Size Market Share by Region
6.2 Global Equine Pharmaceuticals and Supplements Sales by Region
6.2.1 Global Equine Pharmaceuticals and Supplements Sales by Region
6.2.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Region
7 North America Market Overview
7.1 North America Equine Pharmaceuticals and Supplements Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Equine Pharmaceuticals and Supplements Market Size by Type
7.3 North America Equine Pharmaceuticals and Supplements Market Size by Application
8 Europe Market Overview
8.1 Europe Equine Pharmaceuticals and Supplements Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Equine Pharmaceuticals and Supplements Market Size by Type
8.3 Europe Equine Pharmaceuticals and Supplements Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Type
9.3 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Application
10 South America Market Overview
10.1 South America Equine Pharmaceuticals and Supplements Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Equine Pharmaceuticals and Supplements Market Size by Type
10.3 South America Equine Pharmaceuticals and Supplements Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Type
11.3 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Application
12 Equine Pharmaceuticals and Supplements Market Production by Region
12.1 Global Production of Equine Pharmaceuticals and Supplements by Region(2020-2025)
12.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2025)
12.3 Global Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Equine Pharmaceuticals and Supplements Production
12.4.1 North America Equine Pharmaceuticals and Supplements Production Growth Rate (2020-2025)
12.4.2 North America Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Equine Pharmaceuticals and Supplements Production
12.5.1 Europe Equine Pharmaceuticals and Supplements Production Growth Rate (2020-2025)
12.5.2 Europe Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Equine Pharmaceuticals and Supplements Production (2020-2025)
12.6.1 Japan Equine Pharmaceuticals and Supplements Production Growth Rate (2020-2025)
12.6.2 Japan Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Equine Pharmaceuticals and Supplements Production (2020-2025)
12.7.1 China Equine Pharmaceuticals and Supplements Production Growth Rate (2020-2025)
12.7.2 China Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2020-2025)
13 Equine Pharmaceuticals and Supplements Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2033)
13.3 Global Equine Pharmaceuticals and Supplements Market Size Market Share by Type (2020-2033)
13.4 Global Equine Pharmaceuticals and Supplements Price by Type (2020-2033)
14 Equine Pharmaceuticals and Supplements Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Equine Pharmaceuticals and Supplements Market Sales by Application (2020-2033)
14.3 Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2020-2033)
14.4 Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Boehringer Ingelheim
15.1.1 Boehringer Ingelheim Basic Information
15.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
15.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Market Performance
15.1.4 Boehringer Ingelheim Business Overview
15.1.5 Boehringer Ingelheim SWOT Analysis
15.1.6 Boehringer Ingelheim Recent Developments
15.2 Merck Animal Health
15.2.1 Merck Animal Health Basic Information
15.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
15.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
15.2.4 Merck Animal Health Business Overview
15.2.5 Merck Animal Health SWOT Analysis
15.2.6 Merck Animal Health Recent Developments
15.3 Zoetis
15.3.1 Zoetis Basic Information
15.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Overview
15.3.3 Zoetis Equine Pharmaceuticals and Supplements Product Market Performance
15.3.4 Zoetis Business Overview
15.3.5 Zoetis SWOT Analysis
15.3.6 Zoetis Recent Developments
15.4 Bayer Animal Health
15.4.1 Bayer Animal Health Basic Information
15.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
15.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
15.4.4 Bayer Animal Health Business Overview
15.4.5 Bayer Animal Health Recent Developments
15.5 Elanco Animal Health
15.5.1 Elanco Animal Health Basic Information
15.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
15.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
15.5.4 Elanco Animal Health Business Overview
15.5.5 Elanco Animal Health Recent Developments
15.6 Dechra Veterinary Products
15.6.1 Dechra Veterinary Products Basic Information
15.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
15.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Market Performance
15.6.4 Dechra Veterinary Products Business Overview
15.6.5 Dechra Veterinary Products Recent Developments
15.7 CEVA
15.7.1 CEVA Basic Information
15.7.2 CEVA Equine Pharmaceuticals and Supplements Product Overview
15.7.3 CEVA Equine Pharmaceuticals and Supplements Product Market Performance
15.7.4 CEVA Business Overview
15.7.5 CEVA Recent Developments
15.8 Virbac
15.8.1 Virbac Basic Information
15.8.2 Virbac Equine Pharmaceuticals and Supplements Product Overview
15.8.3 Virbac Equine Pharmaceuticals and Supplements Product Market Performance
15.8.4 Virbac Business Overview
15.8.5 Virbac Recent Developments
15.9 Norbrook Equine
15.9.1 Norbrook Equine Basic Information
15.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
15.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product Market Performance
15.9.4 Norbrook Equine Business Overview
15.9.5 Norbrook Equine Recent Developments
15.10 Kyoritsu Seiyaku
15.10.1 Kyoritsu Seiyaku Basic Information
15.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
15.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Market Performance
15.10.4 Kyoritsu Seiyaku Business Overview
15.10.5 Kyoritsu Seiyaku Recent Developments
15.11 Vetoquinol
15.11.1 Vetoquinol Basic Information
15.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
15.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product Market Performance
15.11.4 Vetoquinol Business Overview
15.11.5 Vetoquinol Recent Developments
15.12 Protexin Healthcare
15.12.1 Protexin Healthcare Basic Information
15.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
15.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Market Performance
15.12.4 Protexin Healthcare Business Overview
15.12.5 Protexin Healthcare Recent Developments
15.13 Audevard
15.13.1 Audevard Basic Information
15.13.2 Audevard Equine Pharmaceuticals and Supplements Product Overview
15.13.3 Audevard Equine Pharmaceuticals and Supplements Product Market Performance
15.13.4 Audevard Business Overview
15.13.5 Audevard Recent Developments
15.14 Ouro Fino Saude
15.14.1 Ouro Fino Saude Basic Information
15.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
15.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Market Performance
15.14.4 Ouro Fino Saude Business Overview
15.14.5 Ouro Fino Saude Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 4. Global Equine Pharmaceuticals and Supplements Market Size by Application (M USD)
Table 5. Equine Pharmaceuticals and Supplements Market Size Comparison by Region (M USD)
Table 6. Global Equine Pharmaceuticals and Supplements Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Equine Pharmaceuticals and Supplements Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2024)
Table 11. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Equine Pharmaceuticals and Supplements Manufacturing Sites and Area Served
Table 13. Manufacturers Equine Pharmaceuticals and Supplements Product Type
Table 14. Global Equine Pharmaceuticals and Supplements Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Equine Pharmaceuticals and Supplements Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Equine Pharmaceuticals and Supplements Market Size Comparison by Region (M USD)
Table 26. Global Equine Pharmaceuticals and Supplements Market Size by Region (2020-2033) & (M USD)
Table 27. Global Equine Pharmaceuticals and Supplements Market Size Market Share by Region (2020-2033)
Table 28. Global Equine Pharmaceuticals and Supplements Sales by Region (2020-2033) & (K MT)
Table 29. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2033)
Table 30. North America Equine Pharmaceuticals and Supplements Market Size by Country (2020-2033) & (M USD)
Table 31. North America Equine Pharmaceuticals and Supplements Sales by Country (2020-2033) & (K MT)
Table 32. North America Equine Pharmaceuticals and Supplements Sales by Type (K MT)
Table 33. North America Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 34. North America Equine Pharmaceuticals and Supplements Sales (K MT) by Type (2020-2033)
Table 35. North America Equine Pharmaceuticals and Supplements Market Size (M USD) by Type (2020-2033)
Table 36. North America Equine Pharmaceuticals and Supplements Sales by Application (K MT)
Table 37. North America Equine Pharmaceuticals and Supplements Market Size by Application (M USD)
Table 38. North America Equine Pharmaceuticals and Supplements Sales (K MT) by Application (2020-2033)
Table 39. North America Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2020-2033)
Table 40. Europe Equine Pharmaceuticals and Supplements Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Equine Pharmaceuticals and Supplements Sales by Country (2020-2033) & (K MT)
Table 42. Europe Equine Pharmaceuticals and Supplements Sales by Type (K MT)
Table 43. Europe Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 44. Europe Equine Pharmaceuticals and Supplements Sales (K MT) by Type (2020-2033)
Table 45. Europe Equine Pharmaceuticals and Supplements Market Size (M USD) by Type (2020-2033)
Table 46. Europe Equine Pharmaceuticals and Supplements Sales by Application (K MT)
Table 47. Europe Equine Pharmaceuticals and Supplements Market Size by Application (M USD)
Table 48. Europe Equine Pharmaceuticals and Supplements Sales (K MT) by Application (2020-2033)
Table 49. Europe Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type (K MT)
Table 53. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 54. Asia-Pacific Equine Pharmaceuticals and Supplements Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application (K MT)
Table 57. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Application (M USD)
Table 58. Asia-Pacific Equine Pharmaceuticals and Supplements Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2020-2025)
Table 60. South America Equine Pharmaceuticals and Supplements Market Size by Country (2020-2033) & (M USD)
Table 61. South America Equine Pharmaceuticals and Supplements Sales by Country (2020-2033) & (K MT)
Table 62. South America Equine Pharmaceuticals and Supplements Sales by Type (K MT)
Table 63. South America Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 64. South America Equine Pharmaceuticals and Supplements Sales (K MT) by Type (2020-2033)
Table 65. South America Equine Pharmaceuticals and Supplements Market Size (M USD) by Type (2020-2033)
Table 66. South America Equine Pharmaceuticals and Supplements Sales by Application (K MT)
Table 67. South America Equine Pharmaceuticals and Supplements Market Size by Application (M USD)
Table 68. South America Equine Pharmaceuticals and Supplements Sales (K MT) by Application (2020-2033)
Table 69. South America Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Type (K MT)
Table 73. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 74. Middle East and Africa Equine Pharmaceuticals and Supplements Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Application (K MT)
Table 77. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Application (M USD)
Table 78. Middle East and Africa Equine Pharmaceuticals and Supplements Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2020-2033)
Table 80. Global Equine Pharmaceuticals and Supplements Production (K MT) by Region(2020-2025)
Table 81. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2025)
Table 83. Global Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Equine Pharmaceuticals and Supplements Sales by Type (K MT)
Table 89. Global Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 90. Global Equine Pharmaceuticals and Supplements Sales (K MT) by Type (2020-2033)
Table 91. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2033)
Table 92. Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Type (2020-2033)
Table 93. Global Equine Pharmaceuticals and Supplements Market Size Share by Type (2020-2033)
Table 94. Global Equine Pharmaceuticals and Supplements Sales (K MT) by Application
Table 95. Global Equine Pharmaceuticals and Supplements Market Size by Application(M USD)
Table 96. Global Equine Pharmaceuticals and Supplements Sales by Application (2020-2033) & (K MT)
Table 97. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2033)
Table 98. Global Equine Pharmaceuticals and Supplements Market Size by Application (2020-2033) & (M USD)
Table 99. Global Equine Pharmaceuticals and Supplements Market Share by Application (2020-2033)
Table 100. Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2020-2033)
Table 101. Boehringer Ingelheim Basic Information
Table 102. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
Table 103. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Boehringer Ingelheim Business Overview
Table 105. Boehringer Ingelheim SWOT Analysis
Table 106. Boehringer Ingelheim Recent Developments
Table 107. Merck Animal Health Basic Information
Table 108. Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 109. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Merck Animal Health Business Overview
Table 111. Merck Animal Health SWOT Analysis
Table 112. Merck Animal Health Recent Developments
Table 113. Zoetis Basic Information
Table 114. Zoetis Equine Pharmaceuticals and Supplements Product Overview
Table 115. Zoetis Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Zoetis Business Overview
Table 117. Zoetis SWOT Analysis
Table 118. Zoetis Recent Developments
Table 119. Bayer Animal Health Basic Information
Table 120. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 121. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Bayer Animal Health Business Overview
Table 123. Bayer Animal Health Recent Developments
Table 124. Elanco Animal Health Basic Information
Table 125. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 126. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Elanco Animal Health Business Overview
Table 128. Elanco Animal Health Recent Developments
Table 129. Dechra Veterinary Products Basic Information
Table 130. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
Table 131. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Dechra Veterinary Products Business Overview
Table 133. Dechra Veterinary Products Recent Developments
Table 134. CEVA Basic Information
Table 135. CEVA Equine Pharmaceuticals and Supplements Product Overview
Table 136. CEVA Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. CEVA Business Overview
Table 138. CEVA Recent Developments
Table 139. Virbac Basic Information
Table 140. Virbac Equine Pharmaceuticals and Supplements Product Overview
Table 141. Virbac Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Virbac Business Overview
Table 143. Virbac Recent Developments
Table 144. Norbrook Equine Basic Information
Table 145. Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
Table 146. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Norbrook Equine Business Overview
Table 148. Norbrook Equine Recent Developments
Table 149. Kyoritsu Seiyaku Basic Information
Table 150. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
Table 151. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Kyoritsu Seiyaku Business Overview
Table 153. Kyoritsu Seiyaku Recent Developments
Table 154. Vetoquinol Basic Information
Table 155. Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
Table 156. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Vetoquinol Business Overview
Table 158. Vetoquinol Recent Developments
Table 159. Protexin Healthcare Basic Information
Table 160. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
Table 161. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Protexin Healthcare Business Overview
Table 163. Protexin Healthcare Recent Developments
Table 164. Audevard Basic Information
Table 165. Audevard Equine Pharmaceuticals and Supplements Product Overview
Table 166. Audevard Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Audevard Business Overview
Table 168. Audevard Recent Developments
Table 169. Ouro Fino Saude Basic Information
Table 170. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
Table 171. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Ouro Fino Saude Business Overview
Table 173. Ouro Fino Saude Recent Developments
List of Figures
Figure 1. Product Picture of Equine Pharmaceuticals and Supplements
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Equine Pharmaceuticals and Supplements Market Size (M USD), 2024-2033
Figure 5. Global Equine Pharmaceuticals and Supplements Market Size (M USD) (2020-2033)
Figure 6. Global Equine Pharmaceuticals and Supplements Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Equine Pharmaceuticals and Supplements Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Equine Pharmaceuticals and Supplements Product Life Cycle
Figure 13. Equine Pharmaceuticals and Supplements Sales Share by Manufacturers in 2024
Figure 14. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers in 2024
Figure 15. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Equine Pharmaceuticals and Supplements Revenue in 2024
Figure 18. Industry Chain Map of Equine Pharmaceuticals and Supplements
Figure 19. Global Equine Pharmaceuticals and Supplements Market PEST Analysis
Figure 20. Global Equine Pharmaceuticals and Supplements Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Equine Pharmaceuticals and Supplements Market Size by Region
Figure 27. Global Equine Pharmaceuticals and Supplements Market Size Market Share by Region (2020-2033)
Figure 28. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Equine Pharmaceuticals and Supplements Market Size (M USD) by Country
Figure 33. USA Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Equine Pharmaceuticals and Supplements Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Equine Pharmaceuticals and Supplements Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Equine Pharmaceuticals and Supplements Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Equine Pharmaceuticals and Supplements Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Equine Pharmaceuticals and Supplements Market Size (M USD)by Type
Figure 40. North America Equine Pharmaceuticals and Supplements Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Equine Pharmaceuticals and Supplements Market Size (M USD) by Country
Figure 45. Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Equine Pharmaceuticals and Supplements Market Size (M USD) by Type
Figure 56. Europe Equine Pharmaceuticals and Supplements Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size (M USD) by Country
Figure 61. China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size (M USD) by Type
Figure 72. Asia-Pacific Equine Pharmaceuticals and Supplements Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Equine Pharmaceuticals and Supplements Market Size (M USD) by Country
Figure 77. Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Equine Pharmaceuticals and Supplements Market Size (M USD) by Type
Figure 84. South America Equine Pharmaceuticals and Supplements Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size (M USD) by Country
Figure 89. Saudi Arabia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Equine Pharmaceuticals and Supplements Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size (M USD) by Type
Figure 100. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size (M USD) by Application
Figure 101. Global Equine Pharmaceuticals and Supplements Production Market Share by Region (2020-2025)
Figure 102. North America Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2020-2025)
Figure 105. China Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Figure 108. Sales Market Share of Equine Pharmaceuticals and Supplements by Type (2020-2033)
Figure 109. Sales Market Share of Equine Pharmaceuticals and Supplements by Type in 2024
Figure 110. Market Size Share of Equine Pharmaceuticals and Supplements by Type (2020-2033)
Figure 111. Market Size Share of Equine Pharmaceuticals and Supplements by Type in 2024
Figure 112. Global Equine Pharmaceuticals and Supplements Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Equine Pharmaceuticals and Supplements Market Size by Application(M USD)
Figure 115. Global Equine Pharmaceuticals and Supplements Market Share by Application
Figure 116. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2033)
Figure 117. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2024
Figure 118. Global Equine Pharmaceuticals and Supplements Market Share by Application (2020-2033)
Figure 119. Global Equine Pharmaceuticals and Supplements Market Share by Application in 2024
Figure 120. Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2020-2033)